Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RGS5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PILRA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC286272 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors
SHE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
F9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEC16B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
BCAN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC38A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ESPN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DSC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPM1J - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYP2C9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL4R - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C5orf63 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF660 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FLT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on